These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4883020)

  • 1. [Cause of hyperlipemia in nephrotic syndrome].
    Yoshitoshi Y; Naito C
    Nihon Rinsho; 1968 May; 26(5):1106-16. PubMed ID: 4883020
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical anomalies of the nephrotic syndrome.
    Lewith G; Gabriel R
    Curr Med Res Opin; 1975; 3(4):199-202. PubMed ID: 168035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperlipemia in nephrotic syndrome].
    Walasek L
    Pol Tyg Lek; 1972 Jan; 27(5):189-91. PubMed ID: 4551652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperlipemia in the nephrotic syndrome. Study with intravenous triglycerides loading test].
    Chaptal J; Jean R; Crastes De Paulet A; Crastes De Paulet P; Astruc M
    Arch Fr Pediatr; 1969 Feb; 26(2):231. PubMed ID: 5375884
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abnormal lipid metabolism in nephrotic syndrome].
    Mizobata R; Mune M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():152-5. PubMed ID: 11347048
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some aspects of hyperlipemia in the nephrotic syndrome].
    Guarini G; Costa C; Leri O; Cerulli C
    Minerva Nefrol; 1975; 22(1):54-7. PubMed ID: 1207973
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperlipidemia in nephrotic syndrome].
    Heaf JG
    Ugeskr Laeger; 1991 Aug; 153(35):2414-6. PubMed ID: 1949240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM; Vega GL
    Am J Med; 1989 Nov; 87(5N):3N-11N. PubMed ID: 2486542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the pathochemical characteristics of experimental nephrotic syndrome].
    Nikiforova NV
    Vopr Med Khim; 1967; 13(1):69-73. PubMed ID: 4178088
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperlipidemia of the nephrotic syndrome.
    Kaysen GA
    Kidney Int Suppl; 1991 Apr; 31():S8-15. PubMed ID: 2046275
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mutual relation between hyperlipidemia and nephrotic syndrome].
    Kraise Y; Averbuch M; Schwartz D; Kornovsky R; Levo Y
    Harefuah; 1991 Dec; 121(12):521-4. PubMed ID: 1794760
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipid metabolism in kidney diseases].
    Yoshitoshi Y; Naito C
    Naika; 1968 Oct; 22(4):824-30. PubMed ID: 4884620
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome.
    Gomperts ED; Zucker M; Feesey M; Russel D; Salant D; Joffe BI; Mendelsohn D; Seftel H
    J Lab Clin Med; 1977 Sep; 90(3):529-35. PubMed ID: 578151
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hyperlipidemia in nephrotic syndrome: time for a change?
    Olbricht CJ; Koch KM
    Nephron; 1992; 62(2):125-9. PubMed ID: 1436302
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent trends in the therapy of hyperlipidemia in nephrotic syndrome].
    Campanacci L; Guarnieri GF; Faccini L; Bellini G; Gambari PF
    G Clin Med; 1973 Oct; 54(10):714-33. PubMed ID: 4789301
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipids and nephrotic syndrome.
    J Assoc Physicians India; 1972 Sep; 20(9):701-3. PubMed ID: 4654893
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physiopathology of protein and lipid metabolism in the nephrotic syndrome. Recent experimental and clinical data].
    Costică II; Dumitriu M
    Fiziol Norm Patol; 1972; 18(2):145-54. PubMed ID: 5032189
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dyslipidemia in the nephrotic syndrome. Physiopathological aspects and therapeutic prospects].
    Campanacci L
    Minerva Nefrol; 1975; 22(6):243-51. PubMed ID: 1223701
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.